UAB Pharma Nord Lithuania Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
266,104 |
45,488 |
13,305 |
13,109 |
2,241 |
5.89 |
4.93 |
17,502 |
73,022 |
0 |
90,524 |
2023 |
---|
352,698 |
80,341 |
28,184 |
22,308 |
5,082 |
9.02 |
6.32 |
39,810 |
91,754 |
8,081 |
122,858 |
2024 |
---|
550,179 |
110,036 |
25,920 |
22,751 |
4,550 |
5.73 |
4.14 |
26,561 |
536,177 |
6,716 |
510,767 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
550,179 €56 % *
Sales per employee (€)
110,036 €37 % *
Profit before tax (€)
25,920 €-8 % *
Net Profit (€)
22,751 €2 % *
Profit per employee (€)
4,550 €-10 % *
Total profitability (%)
5.73 %-36.47 % *
Net profitability (%)
4.14 %-34.49 % *
Equity (€)
26,561 €-33 % *
Amounts Payable And Liabilities (€)
536,177 €484 % *
Non-current Assets (€)
6,716 €-17 % *
CurrentAssets (€)
510,767 €316 % *